MTHPC - A drug on its way from second to third generation photosensitizer?

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 2, 2012, Pages 170-179

  Senge, Mathias O ^a,b  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cancer; Foscan; Photodynamic therapy; Photosensitizers; Porphyrins; QSAR; Temoporfin

Indexed keywords

2,3 DIHYDROXY 1 PROPYLOXYPHENYLPORPHYRIN DERIVATIVE; 5,15 BIS(3,5 DIHYDROXYPHENYL)CHLORIN; CHLORINE DERIVATIVE; FOSLIP; FOSPEG; GLYCOPORPHYRIN DERIVATIVE; LIPOSOME; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; TEMOCENE; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TETRAPHENYLPORPHYRIN DERIVATIVE; TETRAPYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; CELLULAR DISTRIBUTION; CHEMICAL MODIFICATION; CYTOTOXICITY; DRUG FORMULATION; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; GLYCOSYLATION; HUMAN; HYDROPHOBICITY; NANOTECHNOLOGY; NONHUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; SYNTHESIS;

HUMANS; MESOPORPHYRINS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84861000042     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.10.001     Document Type: Review

References (94)

1. Dougherty T.J. Photodynamic therapy. Photochem Photobiol 1993, 58:895-900.
2. Kessel D. Photodynamic therapy: from the beginning. Photodiagn Photodyn Ther 2004, 1:3-7.
3. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., et al. Photodynamic therapy. J Natl Cancer Inst 1998, 90:889-905.
4. Pandey R.K., Shiau F.Y., Dougherty T.J., Smith K.M. Regioselective syntheses of ether-linked porphyrin dimers and trimers related to Photofrin II. Tetrahedron 1991, 47:9571-9584.
5. Bonnett R. Chemical aspects of photodynamic therapy 2000, Gordon & Breach Publ., Amsterdam.
6. Nyman E.S., Hynninen P.H. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J Photochem Photobiol B: Biol 2004, 73:1-28.
7. Ethirajan M., Chen Y.H., Joshi P., Pandey R.K. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 2011, 40:340-362.
8. Bonnett R., White R.D., Winfield U.J., Berenbaum M.C. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers. Biochem J 1989, 261:277-280.
9. ®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin), a second generation photosensitizer. Photochem Photobiol 2011, 87:1240-1296.
10. KaŠčáková S., de Visscher S., Kruijt B., de Bruijn H.S., van der Ploeg-van den Heuvel A., Sterenborg H.J.C.M., et al. In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging. Lasers Med Sci 2011, 10.1007/s10103-011-0888-z.
11. Osher J., Jerjes W., Upilea T., Hamdoon Z., Morley S., Hopper C. Adenoid cystic carcinoma of the tongue base treated with ultrasound-guided interstitial photodynamic therapy: a case study. Photodiagn Photodyn Ther 2011, 8:68-71.
12. Jerjes W., Upile T., Hamdoon Z., Abbas S., Akram S., Mosse C.A., et al. Photodynamic therapy: the minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma. Lasers Surg Med 2011, 43:283-292.
13. Berenbaum M.C., Akande S.L., Bonnett R., Kaur H., Ioannou S., White R.D., et al. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumor photosensitizers with favorable selectivity. Br J Cancer 1986, 54:717-725.
14. Buchholz J., Kaser-Hotz B., Khan T., Bley C.R., Melzer K., Schwendener R.A., et al. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Clin Cancer Res 2005, 11:7538-7544.
15. Pegaz B., Debefve E., Ballini J.P., Wagnieres G., Spaniol S., Albrecht V., et al. Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci 2006, 28:134-140.
16. Hefesha H., Loew A., Liu X., May S., Fahr A. Transfer mechanism of temoporfin between liposomal membranes. J Control Release 2011, 150:279-286.
17. Reshetov L.N., Zorina T.E., D'Hallewin M-A., Bolotina L.N., Zorin V.P. Fluorescence methods for detecting the kinetics of photosensitizer release from nanosized carriers. J Appl Spectrosc 2011, 78:103-109. [Zh Prokl Spektrosk 2011;78:114-20].
18. Chen M., Liu X., Fahr A. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: in vitro study with finite and infinite dosage application. Int J Pharm 2011, 408:223-234.
19. Reshetov V., Kachatkou D., Shmigol T., Zorin V., D'Hallewin M-A. Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates. Photochem Photobiol Sci 2011, 10:911-919.
20. de Visscher S.A.H.J., Kascakova S., de Bruijn H.S., van der Ploeg-van den Heuvel A., Amelink A., Sterenborg H.J.C.M., et al. Fluorescence localization and kinetics of mthpc and liposomal formulations of mTHPC in the window-chamber tumor model. Lasers Surg Med 2011, 43:528-536.
21. Kranz S., Guellmar A., Völpel A., Gitter B., Albrecht V., Sigusch B.W. Photodynamic suppression of Enterococcus faecalis using the photosensitizer mTHPC. Lasers Surg Med 2011, 43:241-248.
22. Gyenge E.B., Hiestand S., Graefe S., Walt H., Maake C. Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro. Photodiagn Photodyn Ther 2011, 8:86-96.
23. Löw K., Knobloch T., Wagner S., Wiehe A., Engel A., Langer K., et al. Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells. Nanotechnology 2011, 22. 245102 (12 pp.).
24. Dragicevic-Curic N., Friedrich M., Petersen S., Scheglmann D., Douroumis D., Plass W., et al. Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. Int J Pharm 2011, 412:85-94.
25. Griffiths S.J., Heelis P.F., Haylett A.K., Moore J.V. Photodynamic therapy of ovarian tumours and normal cells using 5,10,15,20-tetra(3-carboxymethylphenyl)-chlorin. Cancer Lett 1998, 125:177-184.
26. Bourre L., Simonneaux G., Ferrand Y., Thibaut S., Lajat Y., Patrice T. Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. J Photochem Photobiol B: Biol 2003, 69:179-192.
27. Ferrand Y., Bourre L., Simmonneaux G., Thibaut S., Odobel F., Lajat Y., et al. Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin. Bioorg Med Chem Lett 2003, 13:833-835.
28. Bourre L., Thibaut S., Fimani M. In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation. Pharmacol Res 2003, 47:253-261.
29. Banfi S., Caruso E., Caprioli S., Mazzagatti L., Canti G., Ravizza R., et al. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells. Bioorg Med Chem 2004, 12:4853-4860.
30. Boscencu R., Ilie M., Socoteanu R., Oliveira A.S., Constantin C., Neagu M., et al. Microwave synthesis, basic spectral and biological evaluation of some copper (II) mesoporphyrinic complexes. Molecules 2010, 15:3731-3743.
31. Hu Z., Pan Y., Wang J., Chen J., Li J., Ren L. Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity. Biomed Pharmacother 2009, 63:155-164.
32. Silva P., Fonseca S.M., Arranja C.T., Burrows H.D., Urbano A.M., Sobral A.J.F.N. A new nonconjugated naphthalene derivative of meso-tetra-(3-hydroxy)-phenyl-porphyrin as a potential sensitizer for photodynamic therapy. Photochem Photobiol 2010, 86:1147-1153.
33. Banfi S., Caruso E., Fiene E., Buccafurni L., Gariboldi M.B., Ravizza R., et al. Synthesis and photodynamic activity of diaryl-porphyrins characterized by the presence of nitro groups. J Porphyrins Phthalocyanines 2006, 10:1319-1326.
34. Banfi S., Caruso E., Buccafurni L., Murano R., Monti E., Gariboldi M., et al. Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling. J Med Chem 2006, 49:3293-3304.
35. Gariboldi M.B., Ravizza R., Baranyai P., Caruso E., Banfi S., Meschini S., et al. Photodynamic effects of novel 5,15-diaryl-tetrapyrrole derivatives on human colon carcinoma cells. Bioorg Med Chem 2009, 17:2009-2016.
36. Serra A., Pineiro M., Santos C.I., Rocha Gonsalves A.M.D., Abrantes M., Laranjo M., et al. In vitro photodynamic activity of 5,15-bis(3-hydroxyphenyl)porphyrin and its halogenated derivatives against cancer cells. Photochem Photobiol 2010, 86:206-212.
37. Songca S.P. In-vitro activity and tissue distribution of new fluorinated meso-tetrahydroxyphenylporphyrin photosensitizers. J Pharm Pharmacol 2001, 53:1469-1476.
38. Songca S.P., Bonnett R., Maes C.M. A convenient route to new fluorinated photodynamic therapeutic photosensitizers based on meso-tetra(hydroxyphenyl)porphyrins. S Afr J Chem 1997, 50:40-47.
39. Songca S.P., Mbatha B. Solubilization of meso-tetraphenylporphyrin photosensitizers by substitution with fluorine and with 2,3-dihydroxy-1-propyloxy groups. J Pharm Pharmacol 2000, 52:1361-1367.
40. Songca S.P., Mbatha B. Synthesis of solubilised meso-tetrahydroxyphenylporphyrin photosensitisers by substitution with 2,3-dihydroxy-1-propyloxy groups. S Afr J Chem 2000, 53:113-118.
41. Olivier D., Bourré L., El-Sabbagh E., Loussouarn D., Simmoneaux G., Valette F., et al. Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats. Surg Neurol 2007, 68:255-263.
42. Strachan J-P., O'Shea D.F., Balasubramanian T., Lindsey J.S. Rational synthesis of meso-substituted chlorin building blocks. J Org Chem 2000, 65:3160-3172.
43. Borbas K.E., Chandrashekar V., Muthiah C., Hooi L.K., Holten D., Lindsey J.S. Design, synthesis, and photophysical characterization of water-soluble chlorins. J Org Chem 2008, 73:3145-3158.
44. Lindsey J.S. Synthetic routes to meso-patterned porphyrins. Acc Chem Res 2010, 43:300-311.
45. Senge M.O. Nucleophilic substitution as a tool for the synthesis of unsymmetrical porphyrins. Acc Chem Res 2005, 38:733-743.
46. Senge M.O. Stirring the porphyrin alphabet soup-functionalization reactions for porphyrins. Chem Commun 2011, 47:1943-1960.
47. Ruzie C., Krayer M., Balasubramanian T., Lindsey J.S. Tailoring a bacteriochlorin building block with cationic, amphipathic, or lipophilic substituents. J Org Chem 2008, 73:5806-5820.
48. Pereira M.M., Monteiro C.J.P., Simões A.V.C., Pinto S.M.A., Abreu A.R., Sá G.F.F.S., et al. Synthesis and photophysical characterization of a library of photostable halogenated bacteriochlorins: an access to near infrared chemistry. Tetrahedron 2010, 66:9545-9551.
49. Dabrowski J.M., Arnaut L.G., Pereira M.M., Monteiro C.J.P., Urbańska K., Simões S., et al. New halogenated water-soluble chlorin and bacteriochlorin as photostable PDT sensitizers: synthesis, spectroscopy, photophysics, and in vitro photosensitizing efficacy. ChemMedChem 2010, 5:1770-1780.
50. Senge M.O., Shaker Y.M., Pintea M., Ryppa C., Hatscher S.S., Ryan A., et al. Synthesis of meso-substituted ABCD-type porphyrins via functionalization reactions. Eur J Org Chem 2010, 23:7-258.
51. Dogutan D.K., Lindsey J.S. Investigation of the scope of a new route to ABCD-bilanes and ABCD-porphyrins. J Org Chem 2008, 73:6727-6742.
52. 2BC-type porphyrins. Tetrahedron 2005, 61:5535-5564.
53. Wiehe A., Simonenko E.J., Senge M.O., Röder B. Hydrophilicity versus hydrophobicity - varying the amphiphilic structure of porphyrins related to the photosensitizer m-THPC. J Porphyrins Phthalocyanines 2001, 5:758-761.
54. Ben-Dror S., Bronshtein I., Wiehe A., Röder B., Senge M.O., Ehrenberg B. On the correlation between hydrophobicity, liposome binding and cellular uptake of porphyrin sensitizers. Photochem Photobiol 2006, 82:695-701.
55. Muresan A.Z., Lindsey J.S. Design and synthesis of water-soluble bioconjugatable trans-AB-porphyrins. Tetrahedron 2008, 64:11440-11448.
56. Huang Y.Y., Mroz P., Zhiyentayev T., Sharma S.K., Balasubramanian T., Ruzie C., et al. In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. J Med Chem 2010, 53:4018-4027.
57. Zheng X., Pandey R.K. Porphyrin-carbohydrate conjugates: impact of carbohydrate moieties in photodynamic therapy (PDT). Anticancer Agents Med Chem 2008, 8:241-268.
58. Oulmi D., Maillard P., Guerquin-Kern J-L., Huel C., Momenteau M. Glycoconjugated porphyrins. 3. Synthesis of flat amphiphilic mixed meso-(glycosylated aryl)arylporphyrins and mixed meso-(glycosylated aryl)alkylporphyrins bearing some mono- and disaccharide groups. J Org Chem 1995, 60:1554-1564.
59. Laville I., Figueiredo T., Loock B., Pigaglio S., Maillard P., Grierson D.S., et al. Synthesis, cellular internalization and photodynamic activity of glucoconjugated derivatives of tri and tetra(meta-hydroxyphenyl)chlorins. Bioorg Med Chem 2003, 11:1643-1652.
60. Hirohara S., Obata M., Saito A., Ogata S-i, Ohtsuki C., Higashida S., et al. Cellular uptake and photocytotoxicity of glycoconjugated porphyrins in HeLa cells. Photochem Photobiol 2004, 80:301-308.
61. Hirohara S., Obata M., Ogata S-i, Ohtsuki C., Higashida S., Ogura S-i, et al. Cellular uptake and photocytotoxicity of glycoconjugated chlorins in HeLa cells. J Photochem Photobiol B: Biol 2005, 78:7-15.
62. Hirohara S., Obata M., Ogura S., Okura I., Higashida S., Ohtsuki C., et al. Hydrophobicity parameters (LogP) of glycoconjugated porphyrins for photodynamic therapy evaluated by reversed phase HPLC. J Porphyrins Phthalocyanines 2004, 8:1289-1292.
63. Canada-Canada F., Bautista-Sanchez A., Taverna M., Prognon P., Maillard P., Grierson D.S., et al. Simple sensitive and simultaneous high-performance liquid chromatography method of glucoconjugated and non-glucoconjugated porphyrins and chlorins using near infra-red fluorescence detection. J Chromatogr B 2005, 821:166-172.
64. Canada-Canada F., Kasselouri A., Prognon P., Maillard P., Grierson D.S., Descroix S., et al. Enhanced detection of seven glucoconjugated and hydroxylated porphyrins and chlorins by nonaqueous capillary electrophoresis combined with stacking. J Chromatogr A 2005, 1068:123-130.
65. Desroches M-C., Bourdon O., Marokro Y., Chaminade P., Blais J., Progron P., et al. Importance of the ionization states of m-THPC for its HPLC fluorescence detection. Luminescence 2001, 16:173-178.
66. Desroches M-C., Layac S., Prognon P., Maillard P., Grierson D.S., Curis E., et al. Speciation of new tri- and tetra-glucoconjugated tetrapyrrolic macrocycles (porphyrins and chlorins): an electronic molecular spectroscopy study. Appl Spectrosc 2003, 57:950-959.
67. Laville I., Pigaglio S., Blais J.C., Loock B., Maillard P., Grierson D.S., et al. A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis. Bioorg Med Chem 2004, 12:3673-3682.
68. Bautista-Sanchez A., Kasselouri A., Desroches M-C., Blais J., Maillard P., de Oliveira D.M., et al. Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins. J Photochem Photobiol B: Biol 2005, 81:154-162.
69. Desroches M-C., Bautista-Sanchez A., Lamotte C., Labeque B., Auchère D., Farinotti R., et al. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat. J Photochem Photobiol B: Biol 2006, 85:56-64.
70. Maillard P., Loock B., Grieson D.S., Laville I., Blais J., Doz F., et al. In vitro phototoxicity of glycoconjugated porphyrins and chlorins in colorectal adenocarcinoma (HT29) and retinoblastoma (Y79) cell lines. Photodiagn Photodyn Ther 2007, 4:261-268.
71. Ibrahim H., Kasselouri A., You C., Maillard P., Rosilio V., Pansu R., et al. Meso-tetraphenyl porphyrin derivatives: the effect of structural modifications on binding to DMPC liposomes and albumin. J Photochem Photobiol A: Chem 2011, 217:10-21.
72. Desroches M-C., Kasselouri A., Meyniel M., Fontaine P., Goldmann M., Prognon P., et al. Incorporation of glycoconjugated porphyrin derivatives into phospholipid monolayers: a screening method for the evaluation of their interaction with a cell membrane. Langmuir 2004, 20:11698-11705.
73. 23Na MRI longitudinal follow-up of PDT in a xenograft model of human retinoblastoma. Photodiagn Photodyn Ther 2009, 6:214-220.
74. Maillard P., Lupu M., Thomas C.D., Mispelter J. Vers un nouveau traitement du rétinoblastome?. Ann Pharm Fr 2010, 68:195-202.
75. Singh S., Aggarwal A., Thompson S., Tomé J.P.C., Zhu X., Samaroo D., et al. Synthesis and photophysical properties of thioglycosylated chlorins, isobacteriochlorins, and bacteriochlorins for bioimaging and diagnostics. Bioconjugate Chem 2010, 21:2136-2146.
76. Locos O.B., Heindl C.C., Corral A., Senge M.O., Scanlan E.M. Efficient synthesis of glycoporphyrins by microwave-mediated clickreactions efficient synthesis of glycoporphyrins by microwave-mediated click reactions. Eur J Org Chem 2010, 102:6-1028.
77. Garcia G., Naud-Martin D., Carrez D., Croisy A., Maillard P. Microwave-mediated 'click-chemistry' synthesis of glycoporphyrin derivatives and in vitro photocytotoxicity for application in photodynamic therapy. Tetrahedron 2011, 67:4924-4932.
78. ®). MedChemComm 2011, 2:616-619.
79. Stockert J.C., Canete M., Juarranz A., Villanueva A., Horobin R.W., Borrell J.I., et al. Porphycenes: facts and prospects in photodynamic therapy of cancer. Curr Med Chem 2007, 14:997-1026.
80. Bugaj A.M. Targeted photodynamic therapy - a promising strategy of tumor treatment. Photochem Photobiol Sci 2011, 10:1097-1109.
81. Postiglione I., Chiaviello A., Palumbo G. Enhancing photodynamic therapy efficacy by combination therapy: dated, current and oncoming strategies. Cancers 2011, 3:2597-2629.
82. Verhille M., Couleaud P., Vanderesse R., Brault D., Barberi-Heyob M., Frochot C. Modulation of photosensitization processes for an improved targeted photodynamic therapy. Curr Med Chem 2010, 17:3925-3943.
83. Sobolev A.S., Jans D.A., Rosenkranz A.A. Targeted intracellular delivery of photosensitizers. Prog Biophys Mol Biol 2000, 73:51-90.
84. Pélegrin A., Folli S., Buchegger F., Mach J-P., Wagnieres G., van den Bergh H. Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer 1991, 67:2529-2537.
85. Vrouenraets M.B., Visser G.W.M., Stewart F.A., Stigter M., Oppelaar H., Postmus P.E., et al. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Cancer Res 1999, 59:1505-1513.
86. Vrouenraets M.B., Visser G.W.M., Stigter M., Oppelaar H., Snow G.B., van Dongen G.A.M.S. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro. Int J Cancer 2002, 98:793-798.
87. Sehgal I., Sibrian-Vazques M., Vicente M.G.H. Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins. J Med Chem 2008, 51:6014-6020.
88. Gravier J., Korchowiec B., Schneider R., Rogalska E. Interaction of amphiphilic chlorin-based photosensitizers with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine monolayers. Chem Phys Lipids 2009, 158:102-109.
89. Low P.S., Henne W.A., Doorneweerd D.D. Discovery and development of folic-acid-basedreceptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008, 41:120-129.
90. Gravier J., Schneider R., Frochot C., Bastogne T., Schmitt F., Didelon J., et al. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies. J Med Chem 2008, 51:3867-3877.
91. Sergeeva N.N., Bakar M.B., Senge M.O. Synthesis, transformations, and comparative studies of porphyryl acrylic acids and their homologues. J Org Chem 2009, 74:1488-1497.
92. Bakar M.B., Oelgemöller M., Senge M.O. Lead structures for applications in photodynamic therapy. Part 2: synthetic studies for photo-triggered release systems of bioconjugate porphyrin photosensitizers. Tetrahedron 2009, 65:7064-7078.
93. Giuntini F., Alonso C.M.A., Boyle R.W. Synthetic approaches for the conjugation of porphyrins and related macrocycles to peptides and proteins. Photochem Photobiol Sci 2011, 10:759-791.
94. Cardenas-Jiron G.I., Santander-Nelli M., Lopez R., Menendez M.I. Quantitative structure property relationships to evaluate the photosensitizing capability in porphyrins and chlorins. Int J Quantum Chem 2011, 111:1570-1582.